Two French infant formula makers have recalled multiple product batches following the government's decision to slash permissible levels of cereulide, a toxin linked to gastrointestinal illness. The move amplifies a global safety crisis that has seen major brands issue recalls across dozens of countries since late last year.
A routine traffic stop in Hazen, Arkansas, escalated into a perilous high-speed pursuit reaching 140 mph, culminating in a lone police chief facing down three suspects with a child in the vehicle. The dramatic confrontation, captured on Reelz's 'On Patrol: Live,' highlights the split-second decisions officers make when public safety and a child's welfare are on the line.
While October's COLA announcement brings temporary relief, a growing body of evidence suggests the formula used to calculate Social Security adjustments fails to reflect the real-world expenses of retirees, creating a persistent and compounding budget gap.
Millions of seniors received a 2.8% Cost-of-Living Adjustment this January, but soaring Medicare premiums and a flawed inflation formula mean their real purchasing power continues to erode, highlighting a systemic crisis for retirees.
Brand incubator Maesa is betting on the growing body care category with the launch of Ontu, a new line bringing high-performance, facial-inspired formulas to Target shelves at accessible price points, capitalizing on shifting consumer skincare rituals.
The historic Williams Formula 1 team has entered a multi-year partnership with AI firm Anthropic, deploying its Claude AI as a strategic tool for engineering and race strategy. This deal marks a significant move as AI companies accelerate their push into elite sports sponsorships.
The historic Farmers' Almanac, famed for its secret weather formula, has been acquired by digital media company Unofficial Networks. The move saves the publication from shuttering, relocates its operations from Maine to New York, and promises a digital-first revival alongside a planned return to print.
German defense giant Rheinmetall has inked a significant, multi-year framework agreement to supply the Dutch armed forces with a range of hand grenades, deepening a strategic partnership that now spans artillery shells to infantry ordnance amid heightened European security concerns.
As cautious optimism returns to Australian markets, investors are scanning the small-cap space for resilient companies with growth potential. We examine three ASX-listed firms, each with a market capitalisation below $700 million, that stand out for their financial health and strategic positioning.
While Wall Street chases the latest weight-loss drug headlines, Novo Nordisk's recent launch of an oral GLP-1 therapy and its entrenched insulin business present a compelling value proposition for long-term investors.
French pharmaceutical giant Sanofi has discontinued development of its experimental mRNA flu vaccine, citing a strategic reprioritization. The decision comes as influenza activity remains high across much of the United States, with significant hospitalizations and deaths reported this season.
A multi-year investigation in North Georgia has led to the indictment of nine individuals accused of running a sophisticated scheme that falsified vehicle paperwork, enabling unlicensed drivers to illegally purchase and register cars while netting over $1 million.
Columbia Financial (NASDAQ: CLBK) has announced a definitive agreement to merge with Northfield Bancorp in an all-stock transaction valued at approximately $597 million. The deal, slated to close in early Q3 2026, coincides with Columbia's planned "second-step" conversion to a fully public company, a move executives say will unlock value and create a leading regional bank in the New Jersey-New York metro area.
Former President Donald Trump's recent endorsement of a weaker U.S. dollar is prompting investors to position for potential policy shifts. We examine the market implications and three investment avenues gaining traction.
Primrose Candy Co., an Illinois-based confectioner with roots stretching back to the Great Depression, has filed for Chapter 11 bankruptcy, citing mounting debts, rising costs, and shifting consumer tastes that have eroded its once-stable business.
A landmark Senate hearing this week will examine the potential cultural and economic fallout of Netflix's proposed acquisition of Warner Bros. Discovery, amid fears it could create an unprecedented 'stream-opoly'.
The FDA has issued a complete response letter for Aquestive Therapeutics' sublingual epinephrine film Anaphylm, citing concerns over packaging and user instructions. The company aims to address the issues and resubmit its application by the third quarter of this year.
A California class-action lawsuit and regulatory actions are challenging Tesla's usage-based insurance model, alleging that its Safety Score algorithm unfairly penalizes drivers with 'false' collision warnings. The case highlights broader concerns about transparency and consumer protection in the growing telematics-driven insurance sector.
In a revealing interview, former NFL quarterback Tim Tebow recounts how coach Bill Belichick asked him to decline a seven-figure endorsement deal—only to be cut days later. Yet, a decade on, Tebow expresses admiration, not bitterness, toward the legendary coach.
Amid a flurry of bank mergers and acquisitions reshaping Texas, San Antonio-based Frost Bank is doubling down on its organic growth strategy. CEO Phil Green asserts the bank has "zero interest" in M&A, positioning itself to win customers dislocated by industry upheaval.
